BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer
BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commissioning and funding of six molecular diagnostic tests for cancer in the NHS in England for 2016/17.
It aims to provide NHS staff – be they commissioner or hospital provider financial staff, clinicians and pathology staff – with a clear understanding how the new funding arrangements for these tests in 2016/17 will operate to support timely and appropriate patient access.
To read the full briefing, click here. For more information, contact BIVDA Chief Executive, Doris-Ann Williams.